VYNE Therapeutics
VYNE
VYNE
93 hedge funds and large institutions have $92.7M invested in VYNE Therapeutics in 2020 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
44% more capital invested
Capital invested by funds: $64.3M → $92.7M (+$28.4M)
0.01% less ownership
Funds ownership: 0.8% → 0.79% (-0.01%)
40% less call options, than puts
Call options by funds: $167K | Put options by funds: $277K
Holders
93
Holding in Top 10
2
Calls
$167K
Puts
$277K
Top Buyers
| 1 | +$17.5M | |
| 2 | +$10.3M | |
| 3 | +$5.56M | |
| 4 |
BlackRock
New York
|
+$5.38M |
| 5 |
6CM
683 Capital Management
New York
|
+$5.35M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$5.94M | |
| 3 | -$3.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2M |